Psychedelic Drug Treatments for Psychiatric Disorders – All You Need to Know!

  • August 5, 2025
  • Online

Discover the Evidence, Ethics, and Emerging Practices in Psychedelic-Assisted Therapy (PAT)

Join leading experts in psychiatry and mental health for an in-depth exploration of the rapidly evolving field of psychedelic-assisted therapy. This webinar will offer a comprehensive look at the clinical, ethical, and therapeutic aspects of psychedelic medicine and its place in modern psychiatric practice.

The renewed clinical interest in psychedelics brings both promise and controversy. Are the benefits being overstated? What are the potential risks? How does PAT differ from conventional therapy? This evidence-based discussion will cover:

  • Clinical use of MDMA, psilocybin and ketamine
  • PAT training and regulation in Australia
  • Ethical and legal considerations
  • The risks versus benefits in clinical applications
  • Psychotherapy integration and limitations

 

Who Should Attend?

Psychiatrists, psychologists, psychotherapists, general practitioners, nurses, mental health clinicians, and trainees in related fields.

Tags

Webinars

Schedule:

7:30 pm - 7:35 pm

Welcome

Welcome and introduction
7:35 pm - 8:05 pm

Psychedelic Assisted Therapies - Integration through Experience -Dr Eli Kotler

Dr. Kotler will share clinical insights from his groundbreaking work, including Australia's first legal use of PAT, and his experience training psychiatrists in trauma-focused psychedelic interventions.
Dr Eli Kotler Dr Eli Kotler
8:05 pm - 8:35 pm

The Difference between Harm and Healing: Foundations of Safety in Psychedelic-Assisted Therapy - Scott Edwards

With over 15 years in adult education, Scott will outline MMA’s national training initiatives, including MDMA and psilocybin rescheduling efforts, and the integration of altered states into therapeutic contexts.
Scott Edwards Scott Edwards
8:35 pm - 9:00 pm

Great and Desperate Cures revisited: Is this a trip we really want to go on (again)? - Prof Patrick McGorry AO

Australia’s leading voice in youth mental health will provide critical reflections on where psychedelics may (or may not) fit in evolving treatment landscapes.
Prof Patrick McGorry AO Prof Patrick McGorry AO
9:00 am - 9:20 pm

Psychedelics and their relation to psychotherapy: new dawn or prelude to disillusion? - A/Prof Anthony Korner

Director, Trauma-Informed Psychotherapy, University of Sydney A nuanced look at the psychotherapeutic frameworks surrounding psychedelic-assisted therapies—raising essential questions around expectations, evidence, and risks.
A/Prof Anthony Korner A/Prof Anthony Korner
9:20 pm - 9:35 pm

Q&A

A/Prof Anthony Korner A/Prof Anthony Korner
Prof Patrick McGorry AO Prof Patrick McGorry AO
Dr Eli Kotler Dr Eli Kotler
Scott Edwards Scott Edwards

Speaker

A/Prof Anthony Korner

MBBS PhD FRANZCP MMed (Psychotherapy) Director, Trauma-Informed Psychotherapy

Dr Eli Kotler

MBBS MPM FRANZCP Cert. Old Age Psych. AFRACMA Australian pioneer of PAT and Director of the Certificate of Psychedelic-Assisted Therapy (CPAT)

Peter Hunt AM

B.Com, LL.B Chair Mind Medicine Australia

Prof Patrick McGorry AO

MBBS MD PhD FRANZCP Executive Director

Prof Philip Morris AM

MBBS BSc PhD FRANZCP FAChAM President, National Association of Practising Psychiatrists

Scott Edwards

BMus,DipRM Mind Medicine Australia Executive Officer

frequently asked questions

Can I get a refund?

Refunds are only available till 7 days prior to the event.

Can I get a Member Discount?

In order to receive a member discount you need to be an approved NAPP member.

Cannot attend the webinar, will there be a recording?

The webinar will be recorded and made available to all participants for a limited period. After that it will only be available to NAPP members.

Do I need a Zoom account for the webinar?

Yes, you need to have your own personal Zoom account to login to the webinar. Zoom accounts are for free and you can get them www.zoom.com and click on the Sign Up Free button.

  • Time : 7:30 pm - 9:30 pm (Australia/Sydney)